Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 12

1.

Patients with hypertension-associated thrombotic microangiopathy may present with complement abnormalities.

Timmermans SAMEG, Abdul-Hamid MA, Vanderlocht J, Damoiseaux JGMC, Reutelingsperger CP, van Paassen P; Limburg Renal Registry.

Kidney Int. 2017 Jun;91(6):1420-1425. doi: 10.1016/j.kint.2016.12.009. Epub 2017 Feb 7.

PMID:
28187980
2.

Anti-PLA2R Antibodies as a Prognostic Factor in PLA2R-Related Membranous Nephropathy.

Timmermans SA, Abdul Hamid MA, Cohen Tervaert JW, Damoiseaux JG, van Paassen P; Limburg Renal Registry.

Am J Nephrol. 2015;42(1):70-7. doi: 10.1159/000437236. Epub 2015 Sep 5.

PMID:
26344651
3.

Connective tissue growth factor and the cicatrization of cellular crescents in ANCA-associated glomerulonephritis.

Hilhorst M, Kok HM, Broekhuizen R, van Paassen P, van Breda Vriesman P, Goldschmeding R, Nguyen TQ, Cohen Tervaert JW; Limburg Renal Registry.

Nephrol Dial Transplant. 2015 Aug;30(8):1291-9. doi: 10.1093/ndt/gfv088. Epub 2015 Apr 26.

PMID:
25916872
4.

Evaluation of anti-PLA2R1 as measured by a novel ELISA in patients with idiopathic membranous nephropathy: a cohort study.

Timmermans SA, Damoiseaux JG, Heerings-Rewinkel PT, Ayalon R, Beck LH Jr, Schlumberger W, Salant DJ, van Paassen P, Tervaert JW; Limburg Renal Registry.

Am J Clin Pathol. 2014 Jul;142(1):29-34. doi: 10.1309/AJCP8QMOY5GLRSFP.

PMID:
24926082
5.

Anti-phospholipase A2 receptor antibodies and malignancy in membranous nephropathy.

Timmermans SA, Ayalon R, van Paassen P, Beck LH Jr, van Rie H, Wirtz JJ, Verseput GH, Frenken LA, Salant DJ, Cohen Tervaert JW; Limburg Renal Registry.

Am J Kidney Dis. 2013 Dec;62(6):1223-5. doi: 10.1053/j.ajkd.2013.07.019. Epub 2013 Sep 8. No abstract available.

PMID:
24021909
6.

Improved outcome in anti-neutrophil cytoplasmic antibody (ANCA)-associated glomerulonephritis: a 30-year follow-up study.

Hilhorst M, Wilde B, van Paassen P, Winkens B, van Breda Vriesman P, Cohen Tervaert JW; Limburg Renal Registry.

Nephrol Dial Transplant. 2013 Feb;28(2):373-9. doi: 10.1093/ndt/gfs428. Epub 2012 Dec 6.

PMID:
23223225
7.

Rosuvastatin and cardiovascular events in patients undergoing hemodialysis.

Fellström BC, Jardine AG, Schmieder RE, Holdaas H, Bannister K, Beutler J, Chae DW, Chevaile A, Cobbe SM, Grönhagen-Riska C, De Lima JJ, Lins R, Mayer G, McMahon AW, Parving HH, Remuzzi G, Samuelsson O, Sonkodi S, Sci D, Süleymanlar G, Tsakiris D, Tesar V, Todorov V, Wiecek A, Wüthrich RP, Gottlow M, Johnsson E, Zannad F; AURORA Study Group.

N Engl J Med. 2009 Apr 2;360(14):1395-407. doi: 10.1056/NEJMoa0810177. Epub 2009 Mar 30. Erratum in: N Engl J Med. 2010 Apr 15;362(15):1450.

8.

False-positive FDG-PET scan due to brown tumours.

van Baardwijk A, de Jong J, Arens A, Thimister P, Verseput G, Kremer B, Lambin P.

Eur J Nucl Med Mol Imaging. 2006 Mar;33(3):393-4. Epub 2005 Dec 30. No abstract available.

PMID:
16385408
9.

ACE inhibition delays development of terminal renal failure in the presence of severe albuminuria.

Verseput GH, Koomans HA, Braam B, Weening JJ, Provoost AP.

Am J Kidney Dis. 2000 Feb;35(2):202-10.

PMID:
10676717
10.

Tubuloglomerular feedback and prolonged ACE-inhibitor treatment in the hypertensive fawn-hooded rat.

Verseput GH, Braam B, Provoost AP, Koomans HA.

Nephrol Dial Transplant. 1998 Apr;13(4):893-9.

PMID:
9568846
11.

Angiotensin-converting enzyme inhibition in the prevention and treatment of chronic renal damage in the hypertensive fawn-hooded rat.

Verseput GH, Provoost AP, Braam BB, Weening JJ, Koomans HA.

J Am Soc Nephrol. 1997 Feb;8(2):249-59.

12.

Supplemental Content

Loading ...
Support Center